Switch to
More onapp

How to use scorecard? Learn more

Divi's Laboratories Ltd

DIVISLAB
Health CareLabs & Life Sciences Services
LargecapWith a market cap of ₹1,57,491 cr, stock is ranked 57
Low RiskStock is 1.81x as volatile as Nifty
5,876.7075.00 (-1.26%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareLabs & Life Sciences Services
LargecapWith a market cap of ₹1,57,491 cr, stock is ranked 57
Low RiskStock is 1.81x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
85.78
PB RatioPB Ratio
11.61
Dividend YieldDiv. Yield
0.51%
Sector PESector PE
51.53
Sector PBSector PB
6.56
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

41%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids.

Brands

Divi's

Pharmaceutical company

Brands

Divi's

Pharmaceutical company

Financial TrendFinancial statements 

20212022202320247.039.078.118.181.982.961.821.60
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 1.18%

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

News Verification 
Announced OnDec 5, 2024

The Exchange has sought clarification from Divi's Laboratories Limited with respect to recent news item captioned Divi's Labs shares fall nearly 3% as US court says Novartis cannot block generic of best-selling heart drug. The response from the Company is attached. | Download

The Exchange has sought clarification from Divi's Laboratories Limited with respect to recent news item captioned Divi's Labs shares fall nearly 3% as US court says Novartis cannot block generic of best-selling heart drug. The response from the Company is attached. | Download

News Verification 
Announced OnDec 5, 2024
The Exchange has sought clarification from Divi's Laboratories Limited with respect to recent news item captioned Divi's Labs shares fall nearly 3% as US court says Novartis cannot block generic of best-selling heart drug. The response from the Company is awaited.
The Exchange has sought clarification from Divi's Laboratories Limited with respect to recent news item captioned Divi's Labs shares fall nearly 3% as US court says Novartis cannot block generic of best-selling heart drug. The response from the Company is awaited.
Cash Dividend 
Ex. DateAug 2, 2024

Final • Div/Share: ₹ 30

See all events